The results showed that TBK1 overexpression in HCC samples with enriched or decreased B cells, and enriched or decreased CD4+ T cells was a significant indicator of poor prognosis (Supplementary Figures 3B, C). This evidence concerns the gene TBK1 and hepatocellular carcinoma.